Ad is loading...
MENU

RGLS Regulus Therapeutics Forecast, Technical & Fundamental Analysis

a developer of pharmaceutical products

Industry Biotechnology
RGLS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
RGLS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I. Advisor
published Earnings

RGLS is expected to report earnings to fall 17.95% to -17 cents per share on March 20

Regulus Therapeutics RGLS Stock Earnings Reports
Q4'24
Est.
$-0.17
Q3'24
Missed
by $0.04
Q2'24
Missed
by $0.05
Q1'24
Missed
by $0.07
Q4'23
Est.
$-0.40
The last earnings report on November 07 showed earnings per share of -20 cents, missing the estimate of -17 cents. With 261.91K shares outstanding, the current market capitalization sits at 93.67M.
A.I. Advisor
published General Information

General Information

a developer of pharmaceutical products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
4224 Campus Point Court
Phone
+1 858 202-6300
Employees
30
Web
https://www.regulusrx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VLDX1.440.06
+4.35%
Velo3D, Inc.
LGFRY14.660.07
+0.48%
Longfor Group Holdings Ltd.
ASCCY17.34-0.10
-0.57%
Asics Corp.
MQBKY147.68-2.55
-1.70%
Macquarie Group, Ltd.
CBSTF0.11-0.01
-4.42%
THE CANNABIST COMPANY HOLDINGS INC.

RGLS and Stocks

Correlation & Price change

A.I.dvisor tells us that RGLS and SPRY have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RGLS and SPRY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RGLS
1D Price
Change %
RGLS100%
-4.67%
SPRY - RGLS
28%
Poorly correlated
-0.71%
NAUT - RGLS
25%
Poorly correlated
-6.50%
CARA - RGLS
25%
Poorly correlated
-5.04%
ANAB - RGLS
24%
Poorly correlated
-5.80%
BBIO - RGLS
24%
Poorly correlated
-1.62%
More